ABOUT THIS EVENT

Celyad Oncology SA (Nasdaq: CYAD), a clinical-stage biotechnology company focused on the discovery and development of chimeric antigen receptor T cell (CAR T) therapies for cancer, rings the Nasdaq Opening Bell remotely from across the country.

Filippo Petti, CEO, rings the Opening Bell alongside the Company’s team in a virtual bell ringing ceremony.